Anti-GP210 antibody titer as a clinical parameter that predicts the long-term outcome of primary biliary cirrhosis under ursodeoxycholic acid treatment.

被引：0
|
作者：
Nakamura, M [1 ]
Shimizu-Yoshida, Y [1 ]
Takii, Y [1 ]
Komori, A [1 ]
Yokoyama, T [1 ]
Ueki, T [1 ]
Daikoku, M [1 ]
Yano, K [1 ]
Matsumoto, T [1 ]
Yatsuhashi, H [1 ]
Ito, M [1 ]
Ishibashi, H [1 ]
机构：
[1] Natl Nagasaki Med Ctr, Clin Res Ctr, Omura, Nagasaki, Japan
来源：
HEPATOLOGY | 2004年 / 40卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：458A / 459A
页数：2
相关论文
共 50 条
  • [41] Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years
    Chan, CW
    Gunsar, F
    Feudjo, M
    Rigamonti, C
    Vlachogiannakos, J
    Carpenter, JR
    Burroughs, AK
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 (03) : 217 - 226
  • [42] LONG-TERM ADMINISTRATION OF URSODEOXYCHOLIC ACID PREVENTS RECURRENCE OF PRIMARY BILIARY CIRRHOSIS AFTER LIVER TRANSPLANTATION
    Bosch, A.
    Dumortier, J.
    Boulch, D. Maucor
    Conti, F.
    Morard, I.
    Rubbia-Brandt, L.
    Scoazec, J. -Y.
    Wendum, D.
    Terris, B.
    Boillot, O.
    Radenne, S.
    Chazouilleres, O.
    Calmus, Y.
    Giostra, E.
    Corpechot, C.
    JOURNAL OF HEPATOLOGY, 2015, 62 : S783 - S783
  • [43] IMPROVEMENT OF BILIARY ENZYME LEVELS AND ITCHING AS A RESULT OF LONG-TERM ADMINISTRATION OF URSODEOXYCHOLIC ACID IN PRIMARY BILIARY-CIRRHOSIS
    MATSUZAKI, Y
    TANAKA, N
    OSUGA, T
    AIKAWA, T
    SHODA, J
    DOI, M
    NAKANO, M
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1990, 85 (01): : 15 - 23
  • [44] Early primary biliary cirrhosis: Biochemical response to treatment and prediction of long-term outcome
    Corpechot, Christophe
    Chazouilleres, Olivier
    Poupon, Raoul
    JOURNAL OF HEPATOLOGY, 2011, 55 (06) : 1361 - 1367
  • [45] Survival of Anti-Mitochondrial Antibody-Positive and -Negative Primary Biliary Cirrhosis Patients on Ursodeoxycholic Acid Treatment
    Meri Koulentaki
    Joanna Moscandrea
    Philipos Dimoulios
    Costas Chatzicostas
    Elias A. Kouroumalis
    Digestive Diseases and Sciences, 2004, 49 : 1190 - 1195
  • [46] Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment
    Koulentaki, M
    Moscandrea, J
    Dimoulios, P
    Chatzicostas, C
    Kouroumalis, EA
    DIGESTIVE DISEASES AND SCIENCES, 2004, 49 (7-8) : 1190 - 1195
  • [47] Prognostic factors and long-term effects of ursodeoxycholic acid on liver biochemical parameters in patients with primary biliary cirrhosis
    van Hoogstraten, HJE
    Hansen, BE
    van Buuren, HR
    ten Kate, FJW
    van Berge-Henegouwen, GP
    Schalm, SW
    JOURNAL OF HEPATOLOGY, 1999, 31 (02) : 256 - 262
  • [48] Long-term clinical outcome of living-donor liver transplantation for primary biliary cirrhosis
    Hashimoto, Etsuko
    Taniai, Makiko
    Yatsuji, Satoru
    Tokushige, Katsutoshi
    Shiratori, Keiko
    Yamamoto, Masakazu
    Fuchinoue, Syouhei
    HEPATOLOGY RESEARCH, 2007, 37 : S455 - S461
  • [49] LONG-TERM URSODEOXYCHOLIC ACID THERAPY REDUCES ANTI-CYTOKERATIN SUBCLASS ANTIBODY-FORMATION RELATED TO BILE-DUCT DESTRUCTION IN PRIMARY BILIARY-CIRRHOSIS
    ODA, M
    KANEKO, H
    KAZEMOTO, S
    ISHII, K
    YOKOMORI, H
    AZUMA, T
    NAKAMURA, M
    TSUCHIYA, M
    GASTROENTEROLOGY, 1993, 104 (04) : A966 - A966
  • [50] Primary biliary cirrhosis: Standard and serial quantitative liver function tests during long term treatment with ursodeoxycholic acid
    VonSchonfeld, J
    Zotz, R
    Beste, M
    Breuer, N
    Goebell, H
    GUT, 1997, 41 : A241 - A241
12345